Prime Medicine, Inc. (PRME)
4.27
-0.06
(-1.39%)
USD |
NASDAQ |
Dec 11, 16:00
4.255
-0.02
(-0.35%)
After-Hours: 20:00
Prime Medicine EPS Diluted (Quarterly): -0.3152 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.58M |
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 51.81M |
| Enterprise Value | 675.63M |
| Gross Profit Margin (Quarterly) | -53.55% |
| Profit Margin (Quarterly) | -4.13K% |
| Earnings Yield | -34.55% |
| Normalized Earnings Yield | -34.51 |